Indication
Multidrug-resistant Tuberculosis
3 clinical trials
9 products
Clinical trial
Novel Triple-dose Tuberculosis Retreatment Regimen: How to Overcome Resistance Without Creating More in NigerStatus: Active (not recruiting), Estimated PCD: 2025-06-01
Product
6EH³R³ZProduct
6EHRZClinical trial
Economic Evaluation of New MDR TB Regimens (PRACTECAL EE)Status: Completed, Estimated PCD: 2022-08-25
Product
BedaquilineProduct
PretomanidProduct
MoxifloxacinProduct
LinezolidProduct
ClofazimineProduct
Standard DrugsClinical trial
The 6-month BPaL(M) Regimen for the Treatment of Patients With MDR/RR-TB: Multicenter, Single-arm, Operational Research, Clinical TrialStatus: Recruiting, Estimated PCD: 2027-12-01
Product
BPaL